The Future Role of the United States in Global Health: Emphasis on Cardiovascular Disease

J Am Coll Cardiol. 2017 Dec 26;70(25):3140-3156. doi: 10.1016/j.jacc.2017.11.009. Epub 2017 Nov 30.

Abstract

U.S. global health investment has focused on detection, treatment, and eradication of infectious diseases such as tuberculosis, malaria, and human immunodeficiency virus/acquired immunodeficiency syndrome, with significant results. Although efforts should be maintained and expanded to provide ongoing therapy for chronic infectious disease, there is a pressing need to meet the challenge of noncommunicable diseases, which constitute the highest burden of diseases globally. A Committee of the National Academies of Sciences, Engineering, and Medicine has made 14 recommendations that require ongoing commitments to eradication of infectious disease and increase the emphasis on chronic diseases such as cardiovascular disease. These include improving early detection and treatment, mitigating disease risk factors, shifting global health infrastructure to include management of cardiovascular disease, developing global partners and private-public ventures to meet infrastructure and funding challenges, streamlining medical product development and supply, increasing research and development capacity, and addressing gaps in global political and institutional leadership to meet the shifting challenge.

Keywords: cardiovascular health; global health; noncommunicable diseases.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / prevention & control*
  • Global Health / statistics & numerical data*
  • Government Programs / methods*
  • Humans
  • International Cooperation
  • Morbidity
  • Patient Advocacy*
  • United States
  • United States Agency for International Development*